UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 8, 2017
BIOLASE, INC.
(Exact name of registrant as specified in charter)
|
|
|
|
|
|
|
Delaware |
|
001-36385 |
|
87-0442441 |
|
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
4 Cromwell
Irvine, California 92618
(Address of principal executive offices) (Zip Code)
(949) 361-1200
(Registrant’s telephone number, including area code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02 Results of Operations and Financial Condition.
On March 8, 2017, BIOLASE, Inc. issued a press release announcing its financial results for the fourth quarter and year ended December 31, 2016. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
d) Exhibits.
The following exhibit is being furnished as part of this Current Report on Form 8-K:
|
Exhibit No. |
|
Description |
|
|
||
|
99.1 |
|
Press Release of BIOLASE, Inc., dated March 8, 2017 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
BIOLASE, INC. |
||
|
|
|
|
|
|
|
March 8, 2017 |
|
By: |
|
/s/ Harold C. Flynn, Jr. |
|
|
|
|
|
|
|
|
|
|
|
Name: Harold C. Flynn, Jr. |
|
|
|
|
|
Title: President and Chief Executive Officer |
|
|
|
|
|
Exhibit No. |
|
Description |
|
|
||
|
99.1 |
|
Press Release of BIOLASE, Inc., dated March 8, 2017 |